GLIOBLASTOMA MULTIFORME (GBM) WHO GRADE IV

Clinical trials for GLIOBLASTOMA MULTIFORME (GBM) WHO GRADE IV explained in plain language.

Never miss a new study

Get alerted when new GLIOBLASTOMA MULTIFORME (GBM) WHO GRADE IV trials appear

Sign up with your email to follow new studies for GLIOBLASTOMA MULTIFORME (GBM) WHO GRADE IV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New radiation 'Smart Bomb' targets deadly brain cancer in global trial

Disease control Recruiting now

This global Phase 3 trial is testing whether adding a new targeted radiation therapy (TLX101-Tx) to standard chemotherapy (lomustine) works better than chemotherapy alone for adults whose aggressive brain cancer (glioblastoma) has returned for the first time. The new therapy aims…

Matched conditions: GLIOBLASTOMA MULTIFORME (GBM) WHO GRADE IV

Phase: PHASE3 • Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited • Aim: Disease control

Last updated Mar 11, 2026 14:52 UTC

GLIOBLASTOMA MULTIFORME (GBM) WHO GRADE IV

Get alerted when new GLIOBLASTOMA MULTIFORME (GBM) WHO GRADE IV trials appear

New radiation 'Smart Bomb' targets deadly brain cancer in global trial